Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.Guests:Michael Cannon, Director of Health Policy Studies, Cato InstituteStacie Dusetzina, Professor of Health Policy, Vanderbilt UniversityDarius Lakdawalla, Chief Scientific Officer, USC Schaeffer CenterPete Loftus, Reporter, Wall Street JournalBen Rome, Assistant Professor of Medicine, Harvard Medical SchoolLeslie Walker, Senior Reporter, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Ver todos los episodios